pillbase.ru

Awiqli

Active substance: insulin icodec

INJECTION, SOLUTION · INSULIN ICODEC 700 U/mL

United StatesActive

Marketing holder: Novo Nordisk Pharmaceutical Industries, LP

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 2
  • Awiqli
    insulin icodec
    EMEA/H/C/005978
    Novo Nordisk A/S
  • Kyinsu
    insulin icodec, semaglutide
    EMEA/H/C/006279
    Novo Nordisk A/S
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12095-c6bc-7c18-ad5a-ad8986d6fc15,01a12098-7042-7842-a495-941631ace610;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0169-3170
Registration status
Active
Dispensing
Prescription only
Route
SUBCUTANEOUS
Sources
  • product · openFDA NDC · 0169-3170 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0169-3170 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0169-3170 · Verified 2026-10-09 · open in source